About Daehan New Pharm
Daehan New Pharm is a publicly listed company based in Gyeongju (South Korea) founded in 1984. Operator of restaurants and food retail outlets. The company has 397 employees. Daehan New Pharm offers products and services including Human Pharmaceuticals and Animal Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is DaehanNupharm Co.,Ltd.
Company details
Founded in 1984, Daehan New Pharm is involved in the food services sector. A network of restaurants and food stores is managed, covering diverse cuisines and concepts. Farming and processing of poultry and seafood products are conducted to support supply chain integrity. Processed foods are distributed and sold through direct operations and franchising arrangements.
- Headquarters Gyeongju, South Korea
- Employees 397
- Stage Public
- SectorsHealthcare
- Website dhnp.co.kr
- Social X Facebook
- Legal Name Daehan Nupharm Co., Ltd.
- Annual Revenue$140.15 M (USD)0.11as on Dec 31, 2025
- Net Profit$10.57 M (USD)-1.36as on Dec 31, 2025
- EBITDA$11.1 M (USD)-29.59as on Dec 31, 2025
- Employee Count397
Products & Services of Daehan New Pharm
Daehan New Pharm offers a comprehensive portfolio of products and services, including Human Pharmaceuticals and Animal Pharmaceuticals.
Human pharmaceuticals are produced and distributed for various health needs, covering areas such as prescription drugs and health functional foods
Animal pharmaceuticals are manufactured for veterinary applications, including products like DH푸졸정 for companion animals
IPO & Listings of Daehan New Pharm
Daehan New Pharm is a publicly listed company on the KRX with ticker symbol 054670 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Feb 2002
- Listed onKRX: 054670
- Listed entityDaehan Nupharm Co., Ltd.
- Exchange sectorHealth technology
- ISINKR7054670005
- Share price5,350.00 KRW (-0.37% on the day) · 2026-10-14
- Market capitalisation75,369,500,914.00 KRW
- Price to earnings3.1
- EPS (diluted, trailing year)1,705.22 KRW
- Dividend yield1.86%
- Volume (last session)11,364
Financials of Daehan New Pharm
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 202.40B KRW | 15.26B KRW | 16.03B KRW |
| 2024 | 202.19B KRW | 15.47B KRW | 22.76B KRW |
| 2023 | 204.22B KRW | 12.54B KRW | 22.34B KRW |
| 2022 | 197.96B KRW | 24.32B KRW | 31.18B KRW |
| 2021 | 166.59B KRW | 15.69B KRW | 29.01B KRW |
Detailed financial statements for Daehan New Pharm
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Daehan New Pharm
The website of Daehan New Pharm (dhnp.co.kr) receives about 9.1K visits a month.
- Monthly visits9.1K
▲ 22.8% vs previous month
Websites whose visitors overlap most with Daehan New Pharm. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bnckorea.co.kr | 100% | 5.9K | #3,176,838 | View details | |
| dhpharm.co.kr | 94% | 13K | #1,991,351 | View details | |
medipana.com | medipana.com | 82% | #266,587 | – | |
medipharmhealth.co.kr | medipharmhealth.co.kr | 82% | #734,516 | – | |
bosa.co.kr | bosa.co.kr | 82% | #127,846 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Daehan New Pharm
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Daehan New Pharm
Complete news archive for Daehan New Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Daehan New Pharm
Daehan New Pharm was founded in 1984.
Daehan New Pharm is headquartered in Gyeongju, South Korea. It is registered at Gyeongju, North Gyeongsang Province, South Korea.
Daehan New Pharm has 397 employees.
Annual revenue of Daehan New Pharm is $140.15M as on Dec 31, 2025.
Founded in 1984, Daehan New Pharm is involved in the food services sector. A network of restaurants and food stores is managed, covering diverse cuisines and concepts. Farming and processing of poultry and seafood products are conducted to support supply chain integrity. Processed foods are distributed and sold through direct operations and franchising arrangements.
Daehan New Pharm offers Human Pharmaceuticals and Animal Pharmaceuticals.
Yes, Daehan New Pharm is publicly traded on KRX under the ticker symbol 054670.
Daehan New Pharm operates through Daehannupharm Co.,Ltd.